Skip to main navigation

Register now for the Ocular Therapeutix Investor Day on June 17

Investors
Patients
Careers
- Benefits
- Open Positions
Contact Us

Search

About
Retinal Disease
Technology
Pipeline
Products

Search

Investors

Overview
Press
Releases
Events &
Presentations
Scientific &
Medical Presentations
SEC
Filings
Corporate
Governance
Stock
Information
FAQs
Email
Alerts

SOL-1 Phase 3 Data Presentation at Vit-Buckle Society

Science Behind the Therapy - Page 7

SOL-1 Phase 3 Trial - Page 27

Translating SOL-1 Results - Page 79

Clinical Evidence - Page 89

About
Company Overview
Management Team
Board of Directors
Global Scientifc
Advisory Board

Investors
Press Releases
Events & Presentations
Scientific & Medical Presentations
SEC Filings
Corporate Governance
Stock Information
FAQs
Email Alerts

Retinal Disease
Technology
Pipeline
Products

© Ocular Therapeutix, Inc. All rights reserved. DEXTENZA is a registered trademark and ELUTYX, AXPAXLI, RETINA EXPERIENCE REDEFINED, OCULAR THERAPEUTIX, and OCULAR THERAPEUTIX Logo are trademarks of Ocular Therapeutix, Inc.

Terms of Use
Privacy Policy
Compliance
Expanded Access Program